113 related articles for article (PubMed ID: 9187239)
21. Glycolipid-binding proteins.
Sasaki T
Chem Phys Lipids; 1985 Aug; 38(1-2):63-77. PubMed ID: 4064224
[TBL] [Abstract][Full Text] [Related]
22. Specific recognition of N-acetylneuraminic acid in the GM2 epitope by human GM2 activator protein.
Li SC; Wu YY; Sugiyama E; Taki T; Kasama T; Casellato R; Sonnino S; Li YT
J Biol Chem; 1995 Oct; 270(41):24246-51. PubMed ID: 7592631
[TBL] [Abstract][Full Text] [Related]
23. The mouse gene encoding the GM2 activator protein (Gm2a): cDNA sequence, expression, and chromosome mapping.
Yamanaka S; Johnson ON; Lyu MS; Kozak CA; Proia RL
Genomics; 1994 Dec; 24(3):601-4. PubMed ID: 7713516
[TBL] [Abstract][Full Text] [Related]
24. GM2 activator protein expression in mouse tissues.
Beccari T; Palmerini CA; Servillo G; Della Fazia MA; Viola Magni MP; Orlacchio A
Biochem Biophys Res Commun; 1994 Oct; 204(2):741-5. PubMed ID: 7980537
[TBL] [Abstract][Full Text] [Related]
25. Activator proteins for lysosomal glycolipid hydrolysis.
Conzelmann E; Sandhoff K
Methods Enzymol; 1987; 138():792-815. PubMed ID: 2885714
[No Abstract] [Full Text] [Related]
26. Identification of a lysosomal protein causing lipid transfer, using a fluorescence assay designed to monitor membrane fusion between rat liver endosomes and lysosomes.
Kuwana T; Mullock BM; Luzio JP
Biochem J; 1995 Jun; 308 ( Pt 3)(Pt 3):937-46. PubMed ID: 8948454
[TBL] [Abstract][Full Text] [Related]
27. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
Conzelmann E; Sandhoff K
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
[TBL] [Abstract][Full Text] [Related]
28. Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.
Hou Y; Tse R; Mahuran DJ
Biochemistry; 1996 Apr; 35(13):3963-9. PubMed ID: 8672428
[TBL] [Abstract][Full Text] [Related]
29. Study of interaction of GM2 activator protein with GM2 using circular dichroism and fluorescence spectroscopy.
Ravasi D; Masserini M; Vecchio G; Li YT; Li SC
Neurochem Res; 2002 Aug; 27(7-8):785-92. PubMed ID: 12374214
[TBL] [Abstract][Full Text] [Related]
30. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis.
Martin DR; Cox NR; Morrison NE; Kennamer DM; Peck SL; Dodson AN; Gentry AS; Griffin B; Rolsma MD; Baker HJ
Acta Neuropathol; 2005 Nov; 110(5):443-50. PubMed ID: 16200419
[TBL] [Abstract][Full Text] [Related]
31. Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization.
Wendeler M; Hoernschemeyer J; John M; Werth N; Schoeniger M; Lemm T; Hartmann R; Kessler H; Sandhoff K
Protein Expr Purif; 2004 Mar; 34(1):147-57. PubMed ID: 14766311
[TBL] [Abstract][Full Text] [Related]
32. Over-expression of a functionally active human GM2-activator protein in Escherichia coli.
Klima H; Klein A; van Echten G; Schwarzmann G; Suzuki K; Sandhoff K
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):571-6. PubMed ID: 8503891
[TBL] [Abstract][Full Text] [Related]
33. A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
Sharma R; Bukovac S; Callahan J; Mahuran D
Biochim Biophys Acta; 2003 Jan; 1637(1):113-8. PubMed ID: 12527415
[TBL] [Abstract][Full Text] [Related]
34. Retrovirus-mediated transfer and expression of beta-hexosaminidase alpha-chain cDNA in human fibroblasts from G(M2)-gangliosidosis B1 variant.
Teixeira CA; Sena-Esteves M; Lopes L; Sá Miranda MC; Ribeiro MG
Hum Gene Ther; 2001 Sep; 12(14):1771-83. PubMed ID: 11560770
[TBL] [Abstract][Full Text] [Related]
35. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
Conzelmann E; Sandhoff K
Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of a GM2-activator deficiency in two patients with GM2-gangliosidosis AB variant.
Schepers U; Glombitza G; Lemm T; Hoffmann A; Chabas A; Ozand P; Sandhoff K
Am J Hum Genet; 1996 Nov; 59(5):1048-56. PubMed ID: 8900233
[TBL] [Abstract][Full Text] [Related]
38. Structural organization and expression of the gene for the mouse GM2 activator protein.
Bertoni C; Appolloni MG; Stirling JL; Li SC; Li YT; Orlacchio A; Beccari T
Mamm Genome; 1997 Feb; 8(2):90-3. PubMed ID: 9060405
[TBL] [Abstract][Full Text] [Related]
39. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
Tse R; Vavougios G; Hou Y; Mahuran DJ
Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
[TBL] [Abstract][Full Text] [Related]
40. Identification of functional domains within the alpha and beta subunits of beta-hexosaminidase A through the expression of alpha-beta fusion proteins.
Tse R; Wu YJ; Vavougios G; Hou Y; Hinek A; Mahuran DJ
Biochemistry; 1996 Aug; 35(33):10894-903. PubMed ID: 8718882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
